MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer |
| |
| Authors: | Jun Hao Shuyu Zhang Yingqi Zhou Cong Liu Xiangui Hu Chenghao Shao |
| |
| Institution: | aDepartment of Pancreatic Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, China;bSchool of Radiation Medicine and Public Health, Medical College of Soochow University, Suzhou 215123, China;cDepartment of Radiation Medicine, Faculty of Naval Medicine, Second Military Medical University, Xiangyin Road, Shanghai 200433, China |
| |
| Abstract: | MicroRNAs (miRNAs) have emerged as important regulators in the development of pancreatic cancer and may be a valuable therapeutic application. DPC4/Smad4 is a critical tumor suppressor involved in the progression of pancreatic cancer, but few studies have been conducted to determine its relationship with miRNAs. In this study, we identify miR-421 as a potential regulator of DPC4/Smad4. We find that in human clinical specimens of pancreatic cancer miR-421 is aberrantly upregulated while DPC4/Smad4 is strongly repressed, and their levels of expression are inversely correlated. Moreover, ectopic expression of miR-421 significantly decreases DPC4/Smad4 protein level in pancreatic cancer cell lines and simultaneously promotes cell proliferation and colony formation in vitro. Our findings identify miR-421 as a potent regulator of DPC4/Smad4, which may provide a novel therapeutic strategy for treatment of DPC4/Smad4-driven pancreatic cancer. |
| |
| Keywords: | Pancreatic cancer MiR-421 DPC4/Smad4 |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
